RSS

Archive | Drugs RSS feed for this section

Heartburn Medications Linked to Kidney Damage

15. April 2016

Comments Off on Heartburn Medications Linked to Kidney Damage

Longterm usage of a typical kind of medication utilized to relieve heartburn, heartburn, and ulcers might result in an enhanced danger of kidney illness and kidney failure, brand-new research study programs. The research, released in the Journal of the American Society of Nephrology, contributes to previous research study that recommends proton-pump inhibitors (PPIs), a group […]

Continue reading...

Tylenol During Pregnancy Linked to Asthma

7. March 2016

Comments Off on Tylenol During Pregnancy Linked to Asthma

Norwegian scientists utilized health information on 95,200 pregnant moms in between 1999 and 2008, and followed 53,169 of their kids after birth. The moms finished surveys on medication usage on their own and their kids. After managing for different health and behavioral attributes, they discovered that prenatal direct exposure to Tylenol was connected with a […]

Continue reading...

Onglyza Linked to Pancreatic Cancer

10. September 2015

Comments Off on Onglyza Linked to Pancreatic Cancer

The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication, partly because it effectively controls blood sugar and does not encourage weight gain like other diabetes medications. The FDA has already recognized the link between Onglyza and a different health threat, heart failure. In April […]

Continue reading...

Actos lawsuit settlement for $2.2 Billion

1. April 2015

Comments Off on Actos lawsuit settlement for $2.2 Billion

Takeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims of hiding its Actos diabetes medicine’s cancer risks in what would be one of the largest U.S. settlements of patient lawsuits targeting drugs or devices. Takeda propose to settle more than 8,000 lawsuits in federal and state courts in the U.S. […]

Continue reading...

Zofran linked to Deaths of Children

5. March 2015

Comments Off on Zofran linked to Deaths of Children

A recent study suggests that Zofran side effects may be fatal for some children. The study examines two children who were given ondansetron and later died of refractory cardiac arrest. A 10-year-old previously healthy boy presented to the emergency room with gastroenteritis symptoms. After intravenous fluids, morphine, antibiotics, and 2 doses of ondansetron, the patient became unresponsive with […]

Continue reading...

Zofran Lawsuit

4. March 2015

Comments Off on Zofran Lawsuit

Zofran Lawsuit Update Several medical studies have highlighted the risk of Zofran side effects, including cleft palate, cleft lip and congenital heart problems Cleft Lip Cleft Palate Heart Defects, including Atrial Septal Defect and Ventricular Septal Defect Hole In The Heart Congenital heart defect Atrial septal defect Ventricular septal defect Tetralogy of Fallot Fetal death In […]

Continue reading...

Zofran NDC numbers in Lawsuit

2. March 2015

Comments Off on Zofran NDC numbers in Lawsuit

The following table lists the NDCs and labelers of ZOFRAN: NDC Trade Name Labeler Name 55154-1132 ZOFRAN CARDINAL HEALTH PHARMACEUTICAL REPACKAGING – EAST PIKE 00173-0442 ZOFRAN GLAXOSMITHKLINE LLC 00173-0446 ZOFRAN GLAXOSMITHKLINE LLC 00173-0447 ZOFRAN GLAXOSMITHKLINE LLC 00173-0489 ZOFRAN GLAXOSMITHKLINE LLC 49349-0858 Zofran REMEDYREPACK INC. If you were prescribed Zofran while you were pregnant and your […]

Continue reading...

Zofran Birth Defect Warning

21. February 2015

Comments Off on Zofran Birth Defect Warning

Attention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has issued an updated warning against Ondansetran, better known by its brand name, Zofran, use in pregnancy discussed in OBGYN News. Zofran is a 5-HT3 receptor antagonist approved by the FDA for preventing nausea and vomiting […]

Continue reading...

GlaxoSmithKline settles for $105 million

4. June 2014

0 Comments

GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45 states to settle charges it improperly marketed the asthma drug Advair and the antidepressants Paxil and Wellbutrin. The states alleged that, to boost drug sales, GlaxoSmithKline invited doctors to lavish meetings and planted speakers at […]

Continue reading...

Pradaxa Lawsuits Settles For $650 Million

30. May 2014

0 Comments

Boehringer Ingelheim Settles US Pradaxa Litigation For $650 Million Boehringer Ingelheim will pay $650 million in a “comprehensive settlement” of lawsuits over Pradaxa drug. The company said that it expects the settlement will resolve about 4,000 current cases against the company in the US. Pradaxa has been bedeviled by reports of excessive bleeding complications. Following […]

Continue reading...